Publications by authors named "Kay Latta"

Claim this Profile
H
High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry.
Jan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, Dieter Haffner, Lars Pape, Kay Latta

Pediatr Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndrome.
Jan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, Lars Pape, Kay Latta

Pediatr Nephrol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1.
Sina Saffe, Katja Doerry, Anja K Büscher, Matthias Hansen, Melanie Rohmann, Kay Latta

Pediatr Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Practice Guideline: Microhematuria in Children and Young Adults.
Kay Latta, Jan Boeckhaus, Ina Weinreich, Angela Borisch, Dominik Müller

Dtsch Arztebl Int· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Macrohematuria in children and adolescents].
Kay Latta

Urologie· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic Changes.
Jan Boeckhaus, Lea Mohr, Hassan Dihazi, Burkhard Tönshoff, Lutz T Weber, Kay Latta

Cells· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical hemolytic uremic syndrome induced by SARS-CoV2 infection in infants with EXOSC3 mutation.
Chantal Van Quekelberghe, Kay Latta, Steffen Kunzmann, Maik Grohmann, Matthias Hansen

Pediatr Nephrol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
Mathilda Bedin, Olivia Boyer, Aude Servais, Yong Li, Laure Villoing-Gaudé, Kay Latta

J Clin Invest· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria.
Kristina Vollbach, Catharina Schuetz, Christian M Hedrich, Fabian Speth, Kirsten Mönkemöller, Kay Latta

Front Pediatr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)".
Rasmus Ehren, Marcus R Benz, Paul T Brinkkötter, Jörg Dötsch, Wolfgang R Eberl, Kay Latta

Pediatr Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.
Rasmus Ehren, Marcus R Benz, Paul T Brinkkötter, Jörg Dötsch, Wolfgang R Eberl, Kay Latta

Pediatr Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Newborn Suffering from Arhinia: Neonatologic Challenges During Primary Care of the Newborn With Bosma Arhinia Microphthalmia Syndrome (BAMS)].
Helen Stromiedel, Chantal Van Quekelberghe, Gökhan Yigit, Ammar Al Naimi, Franz Bahlmann, Kay Latta

Laryngorhinootologie· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
Jan Boeckhaus, Julia Hoefele, Korbinian M Riedhammer, Burkhard Tönshoff, Rasmus Ehren, Kay Latta

Clin Genet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Newborn Suffering from Arhinia: Neonatologic Challenges During Primary Care of the Newborn With Bosma Arhinia Microphthalmia Syndrome (BAMS)].
Helen Stromiedel, Chantal Van Quekelberghe, Gökhan Yigit, Ammar Al Naimi, Franz Bahlmann, Kay Latta

Z Geburtshilfe Neonatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Oliver Gross, Burkhard Tönshoff, Lutz T Weber, Lars Pape, Kay Latta

Kidney Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
Mathilda Bedin, Olivia Boyer, Aude Servais, Yong Li, Laure Villoing-Gaudé, Kay Latta

J Clin Invest· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease.
Tobias Eisenberger, Christian Decker, Milan Hiersche, Ruben C Hamann, Eva Decker, Kay Latta

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium kidney stones.
Kay Latta

N Engl J Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
Gisela Offner, Burkhard Toenshoff, Britta Höcker, Manuela Krauss, Monika Bulla, Kay Latta

Transplantation· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1.
Richard Nissel, Kay Latta, Marie-France Gagnadoux, Deirdre Kelly, Sally Hulton

Transplantation· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary hyperoxaluria--the German experience.
Bernd Hoppe, Kay Latta, Christian von Schnakenburg, Markus J Kemper

Am J Nephrol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy.
Thomas Henne, Kay Latta, Juergen Strehlau, Lars Pape, Jochen H H Ehrich

Transplantation· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children.
Anette Melk, Thomas Henne, Thorsten Kollmar, Jürgen Strehlau, Kay Latta

Kidney Int· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1.
Christian von Schnakenburg, Gill Rumsby, Bernd Hoppe, Kay Latta, Markus Kemper

Pediatr Nephrol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced lupus as a cause of relapsing inflammatory disease after renal transplantation.
Lars Pape, Juergen Strehlau, Kay Latta, Jochen Hh Ehrich, Gisela Offner

Pediatr Transplant· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis